ArticlePharmaceuticals (Basel, Switzerland)2017

Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice.

Laura Ferrer-Font et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.